T Livnat Selected Research

anti-inhibitor coagulant complex

8/2015	Rotation thromboelastometry analysis of clot formation and fibrinolysis in severe thrombocytopenia: effect of fibrinogen, activated prothrombin complex concentrate, and thrombin- activatable fibrinolysis inhibitor.
7/2009	Concomitant infusion of low doses of rFVIIa and FEIBA in haemophilia patients with inhibitors.
7/2008	Effects of factor VIII inhibitor bypassing activity (FEIBA), recombinant factor VIIa or both on thrombin generation in normal and haemophilia A plasma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

T Livnat Research Topics

Disease

5	Hemophilia A (Haemophilia) 05/2018 - 01/2006
5	Hemorrhage 05/2018 - 07/2008
2	Breast Neoplasms (Breast Cancer) 11/2001 - 12/2000
1	Thrombocytopenia (Thrombopenia) 08/2015
1	Hemophilia B (Haemophilia B) 07/2008

Drug/Important Bio-Agent (IBA)

5	recombinant FVIIa (rFVIIa)FDA Link 05/2018 - 01/2006
3	anti-inhibitor coagulant complexIBA 08/2015 - 07/2008
3	Thrombin FDA Link 09/2013 - 01/2006
1	Peptides (Polypeptides)IBA 05/2018
1	Cytidine Triphosphate (CTP)IBA 05/2018
1	Factor VII (Proconvertin)IBA 01/2017
1	Carboxypeptidase B2 (Thrombin Activatable Fibrinolysis Inhibitor)IBA 08/2015
1	Prothrombin (Factor II)IBA 08/2015
1	Fibrinogen (Factor I)FDA Link 08/2015
1	Factor VIII (Coagulation Factor VIII)IBA 07/2008
1	Transforming Growth Factors (Transforming Growth Factor)IBA 11/2001
1	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 11/2001
1	Transforming Growth Factor beta (TGF-beta)IBA 11/2001
1	Tamoxifen FDA LinkGeneric 12/2000
1	Proteins (Proteins, Gene)FDA Link 12/2000

Therapy/Procedure

3	Therapeutics 09/2013 - 07/2008
1	Subcutaneous Injections 05/2018